The First FDA Approved RNAi Therapeutic for the Treatment of the Polyneuropathy of hATTR Amyloidosis
Recorded on October 10, 2018
Sponsored by Alnylam
This webinar will review ONPATTROTM (patisiran) lipid complex injection, APOLLO clinical trial data, dosing & administration, and resources available to both patients and health care professionals.
Dr. Francy Shu
Health Sciences Assistant Clinical Professor
Division of Neuromuscular Medicine
Department of Neurology
David Geffen School of Medicine at University of California, Los Angeles
Ronald Reagan UCLA Medical Center
This webinar is sponsored, developed and presented by the sponsor. The content of the Science & Innovation Theater Webinar and opinions expressed by the presenters are those of the sponsor or presenters and not of the Academy of Managed Care Pharmacy.